Tingyan Shi, MD, PhD, on Clinical Implications of Using Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer

Posted: Tuesday, June 9, 2020

Tingyan Shi, MD, PhD, of Zhongshan Hospital, Fudan University, discusses the possible survival benefits of cytoreductive surgery in selected patients with ovarian cancer and whether the findings are significant enough for clinicians to offer it to patients now.